Biological E receives phase II WHO pre-qualification for oral polio vaccine

Biological E Limited is celebrating a groundbreaking moment! The World Health Organization has officially granted phase II pre-qualification for their Novel Oral Polio Vaccine type 2. This significant step allows for vaccine manufacturing to take place at one dedicated site, bolstering the world’s ongoing battle against polio.